Pao-Yen Lai

Title: Pao-Yen Lai: Innovator in Vaccine Development

Introduction

Pao-Yen Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly in addressing porcine reproductive and respiratory syndrome and associated diseases. His innovative work has implications for animal health and agricultural practices.

Latest Patents

Pao-Yen Lai holds a patent for "Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases." This patent describes a fusion protein that includes an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a translocation peptide, a fusion antigen, an endoplasmic reticulum retention sequence, and optionally a nuclear export signal. The fusion antigen comprises various PRRSV antigens, which are crucial for inducing antigen-specific cell-mediated and humoral responses. He has 1 patent to his name.

Career Highlights

Lai's career is marked by his dedication to advancing vaccine technology. His work at Reber Genetics Co., Ltd. has positioned him as a key player in the development of innovative solutions for animal health challenges. His research has the potential to improve the health and productivity of livestock, which is vital for the agricultural sector.

Collaborations

Pao-Yen Lai has collaborated with talented individuals such as Yu-Hsin Chien and Meng-Ju Tsai. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Pao-Yen Lai's contributions to vaccine development demonstrate his commitment to improving animal health through innovative solutions. His work continues to influence the field and holds promise for future advancements in veterinary medicine.